NCT01034410 - A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Acute Myeloid Leukemia

Interventions

DRUG

AS1411

AS1411 40mg/kg/day or AS1411 80mg/kg/day

DRUG

Cytarabine

Cytarabine 2g/m2 bid Days 4-7

Trial Locations (14)

Taipei Veterans General Hospital, Taipei

Tri-Service General Hospital, Taipei

Changhua Christian Hospial, Changhua

Royal North Shore Hospital, St Leonards

Westmead Hospital, Westmead

The Alfred Hospital, Melbourne

Royal Adelaide Hospital, Adelaide

Royal Perth Hospital, Perth

Weill Medical College of Cornell University, New York

Medical University of South Carolina, Charleston

China Medical University Hospital, Taichung

UCLA, Los Angeles

Christchurch Hospital, Christchurch

National Taiwan University Hospital, Taipei